Binod Dhakal, MD, on Benefit of Cilta-Cel in Earlier Lines of Multiple Myeloma Treatment
The associate professor at Medical College of Wisconsin discussed current studies evaluating cilta-cel and ongoing research.
Binod Dhakal, MD, on Superior PFS With Cilta-Cel Compared to SOC in Multiple Myeloma
The associate professor at Medical College of Wisconsin discussed new findings from the CARTITUDE-4 study.
Binod Dhakal, MD, on Assessing Cilta-Cel in Lenalidomide-Refractory Multiple Myeloma
The associate professor at Medical College of Wisconsin discussed the rationale for the CARTITUDE-4 study and its latest updates.
Binod Dhakal, MD, on Developing Controllable CAR T-Cell Therapies for Multiple Myeloma
The associate professor of medicine at Medical College of Wisconsin discussed advantages of the ARC-SparX platform.
Dr. Dhakal on the Onset of CAR T-Cell Therapy–Induced CRS in Multiple Myeloma
Binod Dhakal, MD, discusses the differences in onset of cytokine release syndrome with CAR T-cell therapies in multiple myeloma.